STK17A/B-IN-1, with the CAS number 3002038-21-0, is a chemical compound that functions as a selective inhibitor of the STK17A and STK17B kinases, which are involved in various cellular processes, including stress response and apoptosis. This compound is characterized by its ability to modulate cellular signaling pathways, making it a valuable tool in research related to cancer and other diseases where these kinases play a critical role. STK17A/B-IN-1 is typically studied in the context of its pharmacological effects, including its potential to induce cell death in cancer cells or to alter the cellular response to stress. Its chemical structure includes specific functional groups that contribute to its binding affinity and selectivity for the target kinases. As with many small molecule inhibitors, the efficacy and specificity of STK17A/B-IN-1 can be influenced by factors such as concentration, cellular context, and the presence of other signaling molecules. Further research is ongoing to fully elucidate its biological effects and potential therapeutic applications.

STK17A/B-IN-1

3002038-21-0: STK17A/B-IN-1, with the CAS number 3002038-21-0, is a chemical compound that functions as a selective inhibitor of the STK17A and STK17B kinases, which are involved in various cellular processes, including stress response and apoptosis. This compound is characterized by its ability to modulate cellular signaling pathways, making it a valuable tool in research related to cancer and other diseases where these kinases play a critical role. STK17A/B-IN-1 is typically studied in the context of its pharmacological effects, including its potential to induce cell death in cancer cells or to alter the cellular response to stress. Its chemical structure includes specific functional groups that contribute to its binding affinity and selectivity for the target kinases. As with many small molecule inhibitors, the efficacy and specificity of STK17A/B-IN-1 can be influenced by factors such as concentration, cellular context, and the presence of other signaling molecules. Further research is ongoing to fully elucidate its biological effects and potential therapeutic applications.

<p>STK17A/B-IN-1 (compound 9) is an orally active, potent, and selective inhibitor of STK17A/B, demonstrating an IC50 of 23 nM for STK17A. This compound is utilized in tumor research.</p>

CAS 3002038-21-0

STK17A/B-IN-1

STK17A/B-IN-1

Ref: TM-T88701